We hypothesized that somatizing patients managed by primary care physicians (PCP) would improve with a relationship-based intervention.
INTRODUCTION
Patients with somatization are common and have physical symptoms with little documented basis in disease 1 . The prevalence of primary care patients with one or more somatizing symptoms ranges from 33% upwards in outpatient settings, and their care has occasioned safety and cost problems 1 .
We recently demonstrated that nurse practitioners (NP) achieved clinically significant improvement following a 12-month intervention for distressed, high-utilizing patients with medically unexplained symptoms (MUS) 1, 2 . However, treatment of MUS by primary care providers has been infrequent and the results are mixed [3] [4] [5] [6] . Not using the cognitive-behavioral treatment (CBT) and antidepressants we used, two studies had no impact on outcomes 3, 5 , while the other showed a decrease in symptoms 6 , according to a recent review of RCTs for treatment of somatoform disorders 4 . This brief report describes a pilot study of MUS treated by primary care physicians (PCP) assisted by a case manager (CM) with an intervention similar to our previous one using NPs.
METHODS

1) Study Design. High-utilizing MUS patients at Henry Ford
Health System (HFHS) were randomly allocated to treatment conducted by trained PCPs and a case manager (CM) or to usual care. The Mental Component Summary (MCS) of the Short Form-36 (SF-36) was evaluated 12 months post-baseline as the primary endpoint 7, 8 . Supplementary outcomes also were measured. 2) Subjects and Settings. Nonclinical criteria included being members of Health Alliance Plan (HAP), an HFHS-owned and operated HMO, for at least 2 years, literate, able to communicate in English, planning to be in the HMO practice for at least 12 months, accessible by telephone, not currently under care of a mental health professional more than once/month, and willingness to see a new PCP for treatment. Exclusion criteria included: medically unstable or unable to ambulate, pregnancy, substance use disorders, actively suicidal, organic mental syndromes, psychosis, or non-severe MUS, defined as the Mental Health (MH) subscale of the SF-36 being >77 7 .
3) Research PCPs and CM. We trained one experienced CM and four experienced PCPs for 24 hours over 6 weeks to deliver the intervention, which focused on antidepressant management, cognitive-behavioral treatment (CBT), and the provider-patient relationship (PPR). The CM received an additional 4 hours didactic and role play training for her telephone work and 4 hours of additional CBT training. Because the position was lost, the CM participated in the care of only the first six Treatment patients. The HFHS IRB approved the study, and patients signed a consent form. 4) Subject identification. From the administrative database (ADB) at two HFHS sites, we randomly selected subjects 18 years or older with at least eight visits yearly for the two years preceding study. From the ADB, we identified ICD-9 diagnosis codes suggesting MUS electronic charts of these patients to identify primary MUS, guided by a reliable rating procedure 10 .
All 19 providers at the two sites agreed that their patients participate. HFHS research team members then called each patient, and subjects who agreed were then further screened with the MH to exclude less severe subjects. 5) Randomization/Blinding. We randomized 1/2 of subjects to treatment (trained PCP/CM teams) and 1/2 to usual care (UC) using a random number generator. 6) Intervention. The intervention was similar to our earlier study except for using PCPs instead of NPs 1,2 , and we only summarize it here. PCPs used CBT focused, for example, on regular visits and specific healthy behaviors. They delivered the CBT in the context of a behaviorally-defined, evidence-based patient-centered method to maximize communication and the provider-patient relationship 11 . Finally, subjects who met Patient Health Questionnaire-9 (PHQ-9) 12 16 ; e) and a satisfaction with the PPR Questionnaire (SQ-1) 17 .
9)
Statistics. For each outcome measure the baseline and last follow-up assessments were analyzed jointly using a linear model with treatment group, time and group by time interaction effects, and an unstructured covariance for the residual error. Time was measured in days from baseline. We estimated the expected change in outcome from baseline to 12 months in each group by least-squares means, and then the difference-in-differences (DID) for the treatment relative to usual care 18 . Sensitivity analyses included ANCOVA testing to determine between-group differences in 12 month outcomes with adjustment for the baseline to reduce confounding by regression to the mean. Unbiased estimates of effect size and 95% confidence intervals were obtained by the method of Wu et al. 19 .
RESULTS
1) Subjects
Of 82 eligible subjects, 44 were interested (54%); 79.6% were African Americans. Of these, 30 were recruited (68%) and followed at one or more post-baseline interviews (15 Treatment and 15 UC). There were 73% females in Treatment and 93% in UC, with an average age of 52.5 years in each group.
2) Randomization Success
At baseline, shown in Table 1 , treatment patients had significantly greater deficits on the MCS (p=0.02), perhaps due to somewhat higher depressive symptoms (CES-D). Treatment and UC control patients were comparable on other measures.
3) Intervention Impact on Outcome
Shown also in Table 1 For all other outcomes, the RTM effects were not very large. Thus there was still a substantive treatment effect after eliminating the RTM effects.
To evaluate the impact of the CM, we compared the nine non-CM intervention cases to the control group. The difference in difference score for MCS was reduced to 3.8 points, suggesting that the CM made a contribution to the strength of the intervention. For CES-D, the difference in difference score remained approximately the same (−15.8 points). Table 2 summarizes key data about the PCPs' process of care.
DISCUSSION
In a small trial using PCPs to manage somatizing patients, we found moderate to large effect sizes for better mental functioning accompanied by improved somatization and pain in the context of high levels of satisfaction with the provider-patient relationship.
We cannot yet view these results as clinically significant, however, because full clinical trials will be needed to say this. Because trained nurse practitioners achieved a clinically significant 4.0 point MCS improvement in this population 2 , we suspect that a full clinical trial using PCPs will produce a much smaller ES. The data also suggest that trained PCPs can obtain even greater MCS improvement with CM participation, a finding supported by the depression literature 21 .
We cannot exclude the possibility that the selected PCPs would have achieved better outcomes with this patient population without any additional training. Pre-post training patients seen by intervention PCP group would be needed to resolve this. We evaluated possible regression to the mean, but our sensitivity analysis using ANCOVA indicated that was not a major issue.
CONCLUSIONS
We have demonstrated moderate to large effect sizes in the direction predicted by previous research. While these encouraging results hold promise that PCPs may be effective with distressed MUS patients, these pilot data with a small number of subjects only allow us to conclude that a full clinical trial is indicated.
